Last reviewed · How we verify
Gamma PN3
At a glance
| Generic name | Gamma PN3 |
|---|---|
| Sponsor | GPN Vaccines |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Gamma PN3 in the Elderly (PHASE1)
- Extension Safety and Immunogenicity Study of GPNV-001 (PHASE1, PHASE2)
- Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |